The Global Bipolar Disorder Drugs and Treatment Industry is poised for sustained expansion, as revealed by a comprehensive study conducted by Future Market Insights (FMI). The study projects a remarkable Compound Annual Growth Rate (CAGR) of 2.72% from the end of 2023 to 2033, showcasing significant growth potential within the market FMI’s insightful analysis reveals a compelling trajectory for the industry, with …